JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2002; 39:923-934
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, M. C.
Right arrow Articles by Sharma, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, M. C.
Right arrow Articles by Sharma, S. K.

Refractory angina pectoris

Mechanism and therapeutic options

Michael C. Kim, MDa, Annapoorna Kini, MDa and Samin K. Sharma, MD, FACCa,*

a Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA



View larger version (19K):

[in a new window]
  		Figure 1 Trial design and results of MUST-EECP. Source: Arora et al. (24), with permission. CAD = coronary artery disease; CCSC = Canadian Cardiovascular Society class; ETT = exercise treadmill test.

 


View larger version (30K):

[in a new window]
  		Figure 2 Percutaneous in situ coronary venous arterialization. Source: Oesterle et al. (50), with permission.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.